News archive

/News archive/

Emotra is granted a patent in Japan

As we have previously announced, Japan is one of Emotra’s high-priority markets. The company has applied for patents in the EU, USA, Canada and Japan. The Japanese patent office has now informed us that Emotra’s Japanese patent application number 2016-516080 has been approved.   180730- Emotra - PM - Patent approved in Japan

By | July 30th, 2018|INVESTORS|Comments Off on Emotra is granted a patent in Japan

Emotra focuses on Europe’s largest cities

As we notified in a previous newsletter and our annual report, Emotra has changed its market introduction strategy for EDOR®. In the first and second quarter of 2018, we have been working the markets more directly and with a greater geographical focus. Given the company’s resources and previous experience, we have chosen to focus our [...]

By | July 5th, 2018|INVESTORS|Comments Off on Emotra focuses on Europe’s largest cities

Emotra: Agreement with research group on compensation for clinical tests

Emotra AB (“Emotra”) hereby announces that an agreement has been reached with a group of researchers at the faculty of medicine at the University of Warsaw. The agreement concerns financial compensation for EDOR® tests in a clinical study. The study in question is a continuation of a research project that was started in connection with [...]

By | May 7th, 2018|INVESTORS|Comments Off on Emotra: Agreement with research group on compensation for clinical tests

Documents for the Annual General Meeting now available

Emotra AB (publ) (“Emotra”) today announces that the Company’s Annual Report for the financial year 2017, as well as other documents required for the Annual General Meeting are available from the Company’s web site (www.emotra.se) as of today, and are also provided upon request by the Company (see address below). 180418 - Emotra- PM - [...]

By | April 18th, 2018|INVESTORS|Comments Off on Documents for the Annual General Meeting now available

Emotra re-engineers its training seminar planning

The board of Emotra AB (“Emotra”) hereby announces that they have carried out a review of the first six EDOR® training seminars and found that they have not been sufficiently cost-effective. Our chosen approach has turned out to be more expensive than anticipated and has not yet produced the expected results. In 2018 we will [...]

By | December 4th, 2017|INVESTORS|Comments Off on Emotra re-engineers its training seminar planning